John B. Moriarty, Chief Legal Officer at Avidity Biosciences, Inc. (RNA), sold 2,374 shares at $72.23 ($171K) on 2026-01-07, disclosed to the SEC on 2026-01-09.
Scheduled sale ($171k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ALXN | SELL | 2018-02-07 | $296K | — | Filing → |
| ALXN | SELL | 2017-03-01 | $438K | — | Filing → |
| ALXN | SELL | 2017-02-10 | $21K | — | Filing → |